Stocks Struggle To Stabilize After Worst Rout Since June
NHGRI’s Strategic Vision Builds Up Diversity, Breaks Down Barriers
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday
Japan’s Shionogi readies Covid-19 vaccine for December trial, says CEO
Fauci: Increased Case Load Not Due To More Testing [Full CNBC Interview]
These 3 Penny Stocks Could Rack up Triple-Digit Gains, Says Leerink
Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly
More testing means more iceberg
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday;
Weekly investment update – Diverging fortunes
Novavax Pushes US Covid-19 Vaccine Trial Start Out To Nov.; Shares Sink 6%
US Open – Panic Selling is back, Hospital Capacity Concerns, Lite scramble for cash, Can we have an ECB surprise? Commodities drop as virus rages
Red State Governors Still Flunk Coronavirus Testing
Europe On The Cusp Of New Lockdowns As Brussels Plots Pan-EU Restrictions: Live Updates
Achieving COVID-19 herd immunity through infection is dangerous, deadly and might not even work
Covid-19 roundup: Novavax delays PhIII trial in US, with PhII data coming Friday; CBER director promises 'safe and effective' vaccine in op-ed
England's contact-tracing system needs better data handling to beat COVID-19
The COVID "Casedemic" & Biden's "Dark Winter" Plan
Via and Hyundai-Aptiv joint venture to offer shared robotaxi rides next year
Seasonal Flu Rates Plunge, Baffling 'Experts' Who Predicted Deadly 'Superbug'
Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot
A disinfection system that could neutralize COVID-19 in a few minutes is developed
Novavax delays U.S. trial of Covid-19 vaccine candidate
Merck says early data from Covid-19 vaccines expected in 2020
Biomarkers could be used in a quick, inexpensive COVID-19 blood screening tool
Coronavirus stimulus checks: Pelosi, Mnuchin talked, but fail to reach deal on Monday
Farnam Street October 2020 Letter: Even Professional Investors Are Neglecting Investment Hygiene
US Open – Justice Barrett, Earnings (HSBC, BP, Pfizer, Merck), CNY, Oil edges higher, Gold a touch softer
BioSig abandons COVID-19 drug trial on safety concerns
Health insurers are starting to roll back coverage for telehealth – even though demand is way up due to COVID-19